IMMUNE CHECKPOINT BLOCKADE (ICB) IN BRAIN METASTASES (BM) FROM ADVANCED SMALL CELL UROTHELIAL CANCER (ASCUC)

被引：0
|
作者：
Wilson, Nathaniel [1 ]
Alhalabi, Omar [2 ]
Hasanov, Elshad [2 ]
Xiao, Lianchun [2 ]
Papadopoulos, John [2 ]
Campbell, Matthew [2 ]
Shah, Amishi [2 ]
Gao, Jianjun [2 ]
Corn, Paul [2 ]
Aparicio, Ana [2 ]
Wang, Jennifer [2 ]
Czerniak, Bogdan [2 ]
Guo, Charles [2 ]
Logothetis, Christopher [2 ]
Li, Jing [2 ]
Choi, Seungtaek [2 ]
Tang, Chad [2 ]
Tannir, Nizar [2 ]
Siefker-Radtke, Arlene [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
241
引用
收藏
页码：A259 / A260
页数：2
相关论文
共 50 条
  • [1] Immune checkpoint blockade (ICB) for first line treatment in non-small-cell lung cancer (NSCLC)
    Rosell, Rafael
    Karachaliou, Niki
    Sosa, Aaron
    Viteri, Santiago
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S408 - S410
  • [2] Immune Checkpoint Blockade in Metastatic Urothelial Cancer
    Balar, Arjun Vasant
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2109 - +
  • [3] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    LUNG CANCER, 2019, 137 : 31 - 37
  • [4] Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
    Vanlaer, N.
    Dirven, I.
    Vounckx, M.
    Tijtgat, J.
    Verhaert, M.
    Aspeslagh, S.
    Decoster, L.
    Rogiers, A.
    Neyns, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1004 - S1004
  • [5] IMMUNE CHECKPOINT INHIBITORS IN SMALL CELL LUNG CANCER PATIENTS DEVELOPING BRAIN METASTASES
    Jessurun, Charissa
    Tewarie, Ishaan
    Hulsbergen, Alexander
    Broekman, Marike
    Smith, Timothy
    Phillips, John
    NEURO-ONCOLOGY, 2021, 23 : 92 - 92
  • [6] Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
    Ashinuma, H.
    Shingyoji, M.
    Iuchi, T.
    Yoshida, Y.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
  • [7] IMMUNE CHECKPOINT BLOCKADE IS ACTIVE IN MELANOMA BRAIN METASTASES
    不详
    CANCER DISCOVERY, 2018, 8 (06) : 672 - 672
  • [8] The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases
    Wu, Xiancheng
    Stabile, Laura P.
    Burns, Timothy F.
    CLINICAL LUNG CANCER, 2024, 25 (06) : 483 - 501
  • [9] Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
    Lavoie, Jean-Michel
    Baichoo, Priya
    Chavez, Elizabeth
    Nappi, Lucia
    Khalaf, Daniel
    Kollmannsberger, Christian K.
    Chi, Kim N.
    Weng, Andrew
    Steidl, Christian
    Eigl, Bernhard J.
    Nissen, Michael
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] CDKN2A alterations as markers of immune checkpoint blockade (ICB) resistance in urothelial carcinoma (UC).
    Nassar, Amin
    Adib, Elio
    Akl, Elie W.
    Abou Alaiwi, Sarah
    Nuzzo, Pier Vitale
    Mouhieddine, Tarek H.
    Sonpavde, Guru
    Haddad, Robert I.
    Giannakis, Marios
    Hodi, Stephen F.
    Choueiri, Toni K.
    Kwiatkowski, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345